|
KLHL11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.69259999852167E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.3910999947272E-08 |
| Normal-vs-Stage2 |
7.364800E-03 |
| Normal-vs-Stage3 |
4.21449997123347E-09 |
| Normal-vs-Stage4 |
5.95069993281072E-10 |
| Stage1-vs-Stage2 |
3.506000E-02 |
| Stage1-vs-Stage3 |
2.107400E-01 |
| Stage1-vs-Stage4 |
2.684200E-02 |
| Stage2-vs-Stage3 |
7.662100E-03 |
| Stage2-vs-Stage4 |
1.898060E-03 |
| Stage3-vs-Stage4 |
3.804600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.20669999548184E-08 |
| Normal-vs-AfricanAmerican |
3.64520000000201E-05 |
| Normal-vs-Asian |
1.11530000013182E-07 |
| Caucasian-vs-AfricanAmerican |
5.507800E-01 |
| Caucasian-vs-Asian |
7.307600E-01 |
| AfricanAmerican-vs-Asian |
4.539200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.58839999118288E-09 |
| Normal-vs-Female |
6.84919999605071E-08 |
| Male-vs-Female |
1.756630E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.18729999562828E-08 |
| Normal-vs-Age(41-60Yrs) |
2.15400000058708E-08 |
| Normal-vs-Age(61-80Yrs) |
2.97249999947624E-07 |
| Normal-vs-Age(81-100Yrs) |
9.358500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.662600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.816400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.002200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.316800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.822400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.501800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.955000E-04 |
| Classical-VS-Follicular |
2.201400E-01 |
| Classical-VS-Other |
1.200180E-01 |
| Classical-VS-Normal |
7.43939999603427E-08 |
| Tall-VS-Follicular |
6.004900E-04 |
| Tall-VS-Other |
5.955600E-01 |
| Tall-VS-Normal |
8.752198965567E-11 |
| Follicular-VS-Other |
1.326140E-02 |
| Follicular-VS-Normal |
1.91586999999105E-05 |
| Other-VS-Normal |
2.44609999999756E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.32229998856582E-09 |
| Normal-vs-N1 |
1.9304999820946E-09 |
| N0-vs-N1 |
1.372040E-02 |
|
|
